ESCALON MEDICAL CORP (ESMC)
Q4-CY2026Q3-CY2026Q2-CY2026Q1-CY2026Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014
Balance Sheet Date2026-Jun-302026-Mar-312025-Dec-312025-Sep-302025-Jun-302025-Mar-312024-Dec-312024-Sep-302024-Jun-302024-Mar-312023-Dec-312023-Sep-302023-Jun-302023-Mar-312022-Dec-312022-Sep-302022-Jun-302022-Mar-312021-Dec-312021-Sep-302021-Jun-302021-Mar-312020-Dec-312020-Sep-302020-Jun-302020-Mar-312019-Dec-312019-Sep-302019-Jun-302019-Mar-312018-Dec-312018-Sep-302018-Jun-302018-Mar-312017-Dec-312017-Sep-302017-Jun-302017-Mar-312016-Dec-312016-Sep-302016-Jun-302016-Mar-312015-Dec-312015-Sep-302015-Jun-302015-Mar-312014-Dec-31
Fiscal PeriodQ4-FY2026Q3-FY2026Q2-FY2026Q1-FY2026Q4-FY2025Q3-FY2025Q2-FY2025Q1-FY2025Q4-FY2024Q3-FY2024Q2-FY2024Q1-FY2024Q4-FY2023Q3-FY2023Q2-FY2023Q1-FY2023Q4-FY2022Q3-FY2022Q2-FY2022Q1-FY2022Q4-FY2021Q3-FY2021Q2-FY2021Q1-FY2021Q4-FY2020Q3-FY2020Q2-FY2020Q1-FY2020Q4-FY2019Q3-FY2019Q2-FY2019Q1-FY2019Q4-FY2018Q3-FY2018Q2-FY2018Q1-FY2018Q4-FY2017Q3-FY2017Q2-FY2017Q1-FY2017Q4-FY2016Q3-FY2016Q2-FY2016Q1-FY2016Q4-FY2015Q3-FY2015Q2-FY2015
Operating Cash Flow(251,180$)280,983$(517,415$)85,008$15,760$30,695$300,941$33,329$(339,871$)175,190$(322,128$)(115,962$)354,927$240,815$39,785$(310,381$)(452,800$)(15,678$)(188,061$)(393,386$)(1,081$)123,137$175,570$541,079$(497,850$)465,025$(142,836$)7,166$(101,332$)(122,663$)(260,526$)11,832$365,135$(115,343$)(215,960$)(387,372$)(465,509$)(128,162$)306,784$(95,225$)(126,158$)
Investing Cash Flow(25,000$)2,825,000$0$(4,421$)(9,247$)9,248$(21,958$)(18,328$)0$(6,687$)0$(7,155$)0$0$(20,780$)(2,910$)(36,061$)(9,390$)(15,611$)0$0$(6,506$)0$500,000$(14,706$)0$0$0$(4,902$)(764$)(61,464$)(9,142$)(14,004$)
Purchases of Property and Equipment0$0$0$4,421$9,247$(9,248$)21,958$18,328$0$
Financing Cash Flow(889$)(100,880$)(17,524$)(10,599$)(6,921$)(10,339$)(10,021$)(12,634$)(6,524$)(10,140$)(10,272$)(10,520$)(9,520$)(3,274$)(1,402$)(1,175$)(1,799$)(1,747$)(1,722$)(1,663$)(940$)(927$)(908$)(889$)649,129$(858$)(842$)(822$)(807$)(781$)36,069$426$(25,426$)(35,000$)75,000$3,000$0$
End Cash Position3,065,468$3,342,537$337,434$615,791$545,835$540,908$520,584$229,696$209,033$564,707$390,441$744,831$889,674$544,320$313,498$275,147$593,869$1,048,500$1,065,956$1,255,824$1,650,970$1,653,087$1,531,033$1,365,954$825,958$695,648$234,927$415,818$409,743$528,280$652,518$415,818$409,743$1,127,920$788,211$429,885$544,118$425,941$538,284$372,533$538,114$618,588$372,533$1,327,135$1,516,761$1,214,817$1,319,184$
Exchange Rate Effect
Dividends Paid
Unlevered Free Cash Flow(251,180$)280,983$(517,415$)80,587$15,760$30,695$300,941$33,329$(349,118$)184,438$(344,086$)(134,290$)354,927$240,815$39,785$(310,381$)(452,800$)(15,678$)(188,061$)(393,386$)(1,081$)123,137$175,570$541,079$(497,850$)465,025$(142,836$)7,166$(101,332$)(122,663$)(260,526$)11,832$365,135$(115,343$)(215,960$)(387,372$)(465,509$)(128,162$)306,784$(95,225$)(126,158$)